CCRAN

CCRAN gratefully acknowledges our Gold Sponsors, AstraZeneca and Johnson & Johnson, for the 4th Annual Pan-Tumour Biomarkers Conference. Their support enables CCRAN to share crucial insights and essential information with those affected by cancer. We deeply appreciate their commitment to advancing innovation and research in precision oncology.

Join us virtually on June 18–19, 2025, for two days of thought-provoking discussions, expert insights, and community connection.

📅 June 18–19, 2026
💻 Virtual and free to attend
✨ New this year: sessions with real-time translation into French and several other languages

👉 Register for free: http://bit.ly/biomarkers26

Today, we celebrate YOU. 💙

On National Cancer Survivors Day, CCRAN honours every Canadian touched by colorectal cancer — those in treatment, those in remission, and the families and caregivers who walk beside them.

Survivorship looks different for everyone. However your journey unfolds, you are not alone. Our community stands with you today and every day.

To every survivor: your strength inspires us. 💙

🩺 What will it take for comprehensive genomic profiling (CGP) to become a standard of care in Canada?

Join this clinician roundtable at CCRAN's 4th Annual Pan-Tumour Biomarkers Conference, where leading frontline clinicians discuss the clinical value of CGP and the conditions needed to enable equitable, informed clinical decision-making across Canada.

This session will explore the challenges and enablers of implementing CGP and identify opportunities to build alignment across care settings, provinces, and specialties.

Key areas of discussion include:
• The role of CGP in supporting more informed treatment decisions
• Key requirements for successfully integrating CGP into clinical care
• Opportunities to strengthen consistency in CGP use across clinical practice

📅 June 19, 2026 | 10:00 – 11:30 a.m. ET
💻 Virtual and free to attend
✨ New this year: sessions available with real-time translation into French and several other languages

👉 Register for free: http://bit.ly/biomarkers26

🤝 Meaningful collaboration among industry partners is crucial to strengthening precision oncology across provinces.

Join this national panel discussion at CCRAN's 4th Annual Pan-Tumour Biomarkers Conference, where experts will examine opportunities to align industry innovation with oncology system priorities to support equitable access to comprehensive genomic profiling (CGP) across Canada.

This session will explore how industry and health system partners can collaborate to navigate operational realities and build sustainable partnerships that advance CGP across jurisdictions.

Key areas of discussion include:
• Strategies for industry partners to advance CGP within Canada’s evolving precision oncology landscape
• Opportunities for cross-sector collaboration to support coordinated approaches to CGP
• Considerations for fostering responsible, sustainable partnerships that align innovation with health system priorities and patient needs

📅 June 18, 2026 | 4:45 – 5:45 p.m. ET
💻 Virtual and free to attend
✨ New this year: sessions available with real-time translation into French and several other languages

👉 Register for free: http://bit.ly/biomarkers26

🧬 As genomic and molecular testing becomes increasingly complex, how can we ensure every patient benefits from consistent, high-quality interpretation of results?

Join this insightful panel discussion at CCRAN's 4th Annual Pan-Tumour Biomarkers Conference, where experts explore the pivotal role of Molecular Tumour Boards (MTBs) in standardizing the interpretation of comprehensive genomic profiling (CGP) and other advanced diagnostic approaches.

This session will examine how MTBs can support consistent clinical decision-making and advance equitable access to precision oncology expertise across Canada.

Key areas of discussion include:
• The evolving role of MTBs in standardizing CGP interpretation and other advanced molecular diagnostics
• Interprovincial variation and challenges in MTB models and emerging collaborative practices
• The importance of clinician education and knowledge-sharing to strengthen genomics literacy and the interpretation of complex molecular reports

📅 June 18, 2026 | 3:15 – 4:45 p.m. ET
💻 Virtual and free to attend
✨ New this year: sessions available with real-time translation into French and several other languages

👉 Register for free: http://bit.ly/biomarkers26

CCRAN gratefully acknowledges our Platinum Sponsor, Merck, for the 4th Annual Pan-Tumour Biomarkers Conference. Their support enables CCRAN to share crucial insights and essential information with those affected by cancer. We deeply appreciate their commitment to advancing innovation and research in precision oncology.

Join us virtually on June 18–19, 2025, for two days of thought-provoking discussions, expert insights, and community connection.

📅 June 18–19, 2026
💻 Virtual and free to attend
✨ New this year: sessions with real-time translation into French and several other languages

👉 Register for free: http://bit.ly/biomarkers26

Join us live TONIGHT on Instagram! 🎥

Tonight at 7:00 – 8:00 p.m. ET, join CCRAN for an Instagram Live event ahead of the 4th Annual Pan-Tumour Biomarkers Conference, taking place June 18–19, 2026.

Join host Don Wood as he sits down with Jennifer Lovrics and Corri Desaulniers for an intimate and engaging conversation about how access to genomic testing has shaped their treatment decisions and overall cancer care experience.

Hear firsthand about the challenge patients face when accessing genomic testing, and why timing can make a meaningful difference in care.

📅 Thursday, June 4, 2026
⏰ 7:00 – 8:00 p.m. ET
📱 Live on Instagram

We'll see you there! 👋

Every cancer journey tells a story. Every patient voice can shape the future of cancer care. 💙

Join this powerful patient panel discussion at CCRAN's 4th Annual Pan-Tumour Biomarkers Conference to learn how comprehensive genomic profiling (CGP) has transformed patients' decision-making journeys across tumour types.

Together, we'll explore how CGP has affected patients' treatment options, communication with care teams, and their overall experience of living with advanced cancer.

Key areas of discussion include:
• The influence of molecular testing, including CGP, on treatment decisions and patient outcomes across tumour types
• Patient perspectives on access to testing, including gaps in availability, geography, timing, and integration into care
• How communication, shared decision-making, and patient experience can inform policy, clinical practice, and health system planning

📅 June 18, 2026 | 2:00 – 3:00 p.m. ET
💻 Virtual and free to attend
✨ New this year: sessions available with real-time translation into French and several other languages

👉 Register for free: http://bit.ly/biomarkers26